ACH-4471: Interim Phase Ia data

Interim data from a double-blind, placebo-controlled, New Zealand Phase Ia trial in 36 healthy volunteers showed that single doses of 200, 600 and 1,200 mg oral ACH-4471 and 2 doses of 1,200 mg oral A...